Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
Clinical trial NCT00333840 · COMPLETED
Trial details
- NCT number
- NCT00333840
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-06-01
- Primary completion
- 2012-03-01
- Enrollment
- 1106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.